Sugen's Modest Financing Victory
Executive Summary
Sugen's strategy of a private placement of senior convertible debt solves a dilemma for biotechs that once had hot technologies but now find themselves lost with products in the early stages of clinical trials--how to raise money without diluting an already depressed stock price.